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Can pharmacist-led appointments
for blood pressure management 
positively impact 
hypertension metrics?
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BACKGROUND:
- High blood pressure is a major risk factor for
heart disease and stroke, two of the leading
causes of death for all Americans.1
- Optimal blood pressure (BP) management often
requires frequent monitoring and follow-up,
which primary care physicians (PCPs) can have
difficulty maintaining. 2
- Evidence supports pharmacist-led hypertension
(HTN) management, as it can result in BP
reduction.3
OUTCOMES:
- Primary outcome:
 Evaluate the impact of pharmacist-led HTN
management on HTN metric data
- Secondary outcomes:
 Number of medication interventions made
during each visit
 Change in BP within 4 months compared to
patients being managed by PCP
METHODOLOGY:
- Primary outcome:
 Hypertension metric inventory, defined as:
o Percentage of patients whose most
recent blood pressure was at goal
 HTN metric goal defined as:
o Age 18-59 years: ≤ 140/90
o Age 60+ years: ≤ 150/90
o Pt w/ diabetes: ≤ 140/90
- Secondary outcomes:
 Patients who had a clinical pharmacy
specialist (CPS) visit for hypertension
between February 2019 to November 2019
were identified
 Chart reviews were utilized to obtain data
 Propensity matching was used to identify an
equivalent number of patients within
included clinics whose HTN was managed by
their PCP
 Two-tail sample t test compared the systolic
BP reduction between the two groups
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LIMITATIONS:
- HTN metric definition changed during the study
- Patients seen by CPS only account for a small
percentage of the overall metric population
- HTN metric does not always correlate with
patient-specific BP goal
- Propensity matching did not match groups for
baseline BP
CONCLUSIONS:
- The overall decrease in the HTN metric does
not suggest pharmacist-led appointments can
positively impact the metric; however, changes
in the metric definition interfered with proper
assessment.
- Pharmacists provided an average of 2.2
medication interventions per patient, most
commonly being adding a medication (52%),
dose adjustment (42%), and discontinuation
(28%).
- There was a statistically significant systolic BP
reduction in the CPS group compared to the
PCP group (p = 0.04); however, more patients in
the PCP group were at their BP goal initially.
- Overall, pharmacists were able to optimize
medication regimens during visits, and almost
half of the patients seen by a pharmacist were
able to achieve their BP goal within 4 months.
Baseline Characteristics
Demographics
CPS patients
(n=50)
PCP patients 
(n=50)
Age, years, mean (range) 67.9 (35-94) 70.7 (46-89)
Age over 75, no. (%) 17 (34) 17 (34)
Sex, female, no. (%) 24 (48) 24 (48)
BMI, average (range) 31.6 (20-54) 31.5 (22-46)
Comorbidities, n (%)
Clinical ASCVD 12 (24) 17 (34)
Atrial fibrillation 3 (6) 7 (14)
Heart failure 4 (8) 5 (10)
Diabetes 13 (26) 17 (34)
CKD 5 (10) 8 (16)
Secondary Outcomes Data
Blood pressure, %
CPS patients 
(n=50)
PCP patients 
(n=50)
At goal during initial visit 38 76
At goal during final visit 80 94
Average change in SBP -17 mmHg -8 mmHg
Average change in DBP -5.8 mmHg -2.9 mmHg
Interventions, %
CPS patients
(n=50)
PCP patients 
(n=50)
Medication added 52 26
Medication discontinued 28 20
Medication dose 
adjustment
42 28
Non-HTN medication 
intervention
22 N/A
Total # of interventions 
per patient, 
average (range)
2.2 ( 0-7) N/A
Primary Outcome Data
Hypertension 
Metric (%)
Before CPS-led HTN 
visits established
After CPS-led HTN visits 
established
Clinic A 74.7 73.5
Clinic B 72.2 65.5
RESULTS:
